The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to pharmaceutical companies Pfizer and Eli Lilly.

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with nmHSPC, but only as a combination therapy.

Pfizer has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...

Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient models from Eli Lilly and Novo Nordisk.

A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly even costing lives.

Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.

ABBV's oncology sales might have dipped in Q2 as gains from newer drugs face pressure from Imbruvica's ongoing decline.

But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single ...

The amended dosing regimen was approved based on results from a post hoc analysis of the phase 2 MagnetisMM-3 trial.

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...